However, MAS, secondary hemophagocytic lymphohistiocytosis followed by rheumatic diseases, occurs even in patients with s-JIA and AOSD receiving IL-1 and IL-6 inhibitors (63–67). The gene discussed is IL1A; the disease is juvenile idiopathic arthritis.